Isoptin (Verapamil Hydrochloride)

Verapamil blocks L‑type calcium channels in cardiac muscle and vascular smooth muscle. This reduces calcium entry into cells, leading to decreased heart muscle contractility, slowed conduction through the atrioventricular node, and relaxation of arterial walls, which together lower blood pressure, reduce heart workload, and stabilize heart rhythm.

The specific dose of Isoptin is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other factors. Healthcare professionals tailor the dosage to achieve optimal blood‑pressure control, angina relief, or rhythm management while monitoring for safety.

Safety data for verapamil in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and risks with their healthcare provider.

To place an order, submit an enquiry on the Isoptin product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Isoptin (verapamil) is a non‑dihydropyridine calcium‑channel blocker, distinguished by its pronounced effects on cardiac conduction and contractility. Compared with dihydropyridine agents such as amlodipine, verapamil more strongly reduces heart rate and AV‑node conduction, making it useful for rhythm control, whereas dihydropyridines primarily cause vasodilation with less impact on heart rate.

Isoptin should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Isoptin is taken orally, usually as a tablet, with or without food as directed by the prescriber. Patients should swallow the tablet whole with a full glass of water and follow the dosing schedule provided by their healthcare professional.

Serious risks include marked bradycardia, severe hypotension, and conduction disturbances such as AV‑block. These events may require immediate medical attention, dose adjustment, or discontinuation of therapy. Patients should be monitored for signs of these complications, especially during treatment initiation or dosage changes.

Isoptin is contraindicated in patients with severe sinus bradycardia, second‑ or third‑degree AV‑block without a pacemaker, sick sinus syndrome, or uncontrolled heart failure. Individuals with known hypersensitivity to verapamil or any component of the formulation should also avoid its use.